ArticleProceedings of the National Academy of Sciences of the United States of America2014

Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.

Youssif Mohammed Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.